Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Surachno

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Thrombosis and Haemostasis|August 30, 1985
The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysisC P Henny, H ten Cate, S Surachno, et al.
Transplantation|August 27, 1997
Influence of HLA-DRB1* incompatibility on the occurrence of rejection episodes and graft survival in serologically HLA-DR-matched renal transplant combinationsN M Lardy, A R van der Horst, I J ten Berge, et al.
Lancet (London, England)|April 23, 1983
Use of a new heparinoid as anticoagulant during acute haemodialysis of patients with bleeding complicationsC P Henny, H Ten Cate, J W Ten Cate, et al.
Thrombosis Research|July 15, 1985
Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patientsH ten Cate, C P Henny, J W ten Cate, et al.
Clinical and Experimental Immunology|August 22, 2003
Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibodyR T Meijer, S Surachno, S L Yong, et al.
Transplantation Proceedings|December 26, 2001
Differentiation of CMV-specific CD8(POS) T lymphocytes in primary CMV infection after renal transplantationI J ten Berge, L E Gamadia, E B Remmerswaal, et al.
Clinical Transplantation|April 30, 2009
No apparent impact of increased post-operative blood glucose levels on clinical outcome in kidney transplant recipientsTijs J van den Berg, Hein Bogers, Titia M Vriesendorp, et al.
Transplantation Proceedings|March 27, 2001
CMV-specific CD8(pos) T lymphocyte differentiation in latent CMV infectionL E Gamadia, R J Rentenaar, E B Remmerswaal, et al.
Blood|July 27, 2001
Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriersL E Gamadia, R J Rentenaar, P A Baars, et al.
Transplantation Proceedings|March 27, 2001
CD8(POS) lymphocyte dynamics in primary CMV infectionR J Rentenaar, L E Gamadia, N van der Hoek, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Thrombosis and Haemostasis|August 30, 1985
The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysisC P Henny, H ten Cate, S Surachno, et al.
Transplantation|August 27, 1997
Influence of HLA-DRB1* incompatibility on the occurrence of rejection episodes and graft survival in serologically HLA-DR-matched renal transplant combinationsN M Lardy, A R van der Horst, I J ten Berge, et al.
Lancet (London, England)|April 23, 1983
Use of a new heparinoid as anticoagulant during acute haemodialysis of patients with bleeding complicationsC P Henny, H Ten Cate, J W Ten Cate, et al.
Thrombosis Research|July 15, 1985
Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patientsH ten Cate, C P Henny, J W ten Cate, et al.
Clinical and Experimental Immunology|August 22, 2003
Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibodyR T Meijer, S Surachno, S L Yong, et al.
Transplantation Proceedings|December 26, 2001
Differentiation of CMV-specific CD8(POS) T lymphocytes in primary CMV infection after renal transplantationI J ten Berge, L E Gamadia, E B Remmerswaal, et al.
Clinical Transplantation|April 30, 2009
No apparent impact of increased post-operative blood glucose levels on clinical outcome in kidney transplant recipientsTijs J van den Berg, Hein Bogers, Titia M Vriesendorp, et al.
Transplantation Proceedings|March 27, 2001
CMV-specific CD8(pos) T lymphocyte differentiation in latent CMV infectionL E Gamadia, R J Rentenaar, E B Remmerswaal, et al.
Blood|July 27, 2001
Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriersL E Gamadia, R J Rentenaar, P A Baars, et al.
Transplantation Proceedings|March 27, 2001
CD8(POS) lymphocyte dynamics in primary CMV infectionR J Rentenaar, L E Gamadia, N van der Hoek, et al.
Pageof 5